பெப்டைட் ஹார்மோன்கள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from பெப்டைட் ஹார்மோன்கள். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In பெப்டைட் ஹார்மோன்கள் Today - Breaking & Trending Today

Biocon gains on partering IDF to promote diabetes care


Biocon rose 1.08% to Rs 412 after the company said its subsidiary, Biocon Biologics, partnered International Diabetes Federation (IDF) to promote diabetes care, prevention and effective management worldwide.This partnership with IDF coincides with the start of the centenary celebrations of the discovery of insulin and takes forward Biocon Biologics mission of enabling affordable access to insulins to people with diabetes worldwide. The partnership further strengthens the shared vision of providing universal access to insulins globally to tackle a broad range of diabetes issues, create awareness, educate and advocate effective management of diabetes.
DrAlexander Zach,Global Head of Market Access & Policy, Biocon Biologics, said: We are delighted to partner with the International Diabetes Federation and contribute to a stronger global voice for people living with diabetes. Despite 100 years since its discovery, a key impediment to successful diabetes treatment with insulins i ....

Dralexander Zach , Biocon Biologics , International Diabetes Federation , Biocon Biologic , Alexander Zach , Global Head , Market Access , Capital Market , Life Sciences , Clinical Medicine , Peptide Hormones , Recombinant Proteins , Companies Based In Bangalore , Type 1 Diabetes , Long Term , பயோகான் உயிரியல் , சர்வதேச நீரிழிவு நோய் கூட்டமைப்பு , அலெக்சாண்டர் ஸ்யாக் , உலகளாவிய தலை , சந்தை நுழைவு , மூலதனம் சந்தை , வாழ்க்கை அறிவியல் , மருத்துவ மருந்து , உயிரி தொழில்நுட்பவியல் , பெப்டைட் ஹார்மோன்கள் , மறுசீரமைப்பு ப்ரோடீந்ஸ் ,

Biocon's unit Biocon Biologics receives approval for Kixelle


Biocon Biologics, a subsidiary of Biocon has announced that Kixelle, a biosimilar Insulin Aspart co-developed with Viatris Inc, has received marketing authorization approval from the European Commission.
Biocon said that approval was received following the positive recommendation by the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency.
Kixelle, a fast-acting insulin analog indicated for the treatment of diabetes mellitus in adults, adolescents and children aged 1 year and above, has been approved as a 100 units/ml solution for injection in vial and pre-filled pen presentations. The centralized marketing authorization granted by the EC is valid in all EU Member States as well as in the European Economic Area (EEA) countries Iceland, Liechtenstein and Norway. ....

Biocon Biologics , European Medicines Agency , European Commission , Viatris Inc , Committee For Medicinal Products Human Use , Insulin Aspart , Medicinal Products , Human Use , European Medicines , European Economic Area , Insulin Glargine , Capital Market , Life Sciences , Recombinant Proteins , Peptide Hormones , Companies Based In Bangalore , The European Medicines Agency , Committee For Medicinal , பயோகான் உயிரியல் , ஐரோப்பிய தரகு , குழு க்கு மருத்துவ ப்ராடக்ட்ஸ் மனிதன் பயன்பாடு , மருத்துவ ப்ராடக்ட்ஸ் , மனிதன் பயன்பாடு , ஐரோப்பிய மருந்துகள் , ஐரோப்பிய பொருளாதார பரப்பளவு , மூலதனம் சந்தை ,

Raquel Pennington Accepts Six-Month Reduced Suspension for USADA Violation


The US Anti-Doping Agency has issued a statement today confirming that UFC fighter and former title contender Raquel Pennington has accepted a six-month suspension for a USADA violation. However, due to her forthright admission of her use of the substances she was prescribed by a daughter, suspension was reduced for her full cooperation.
Pennington self-reported the use of two banned substances, 7-keto-DHEA and AOD-9064, to USADA on November 17, 2020. Additionally, 7-keto-DHEA (7-keto-dehydroepiandrosterone) is a non-Specified Substance in the class of Anabolic Agents, and AOD-9064 is a non-Specified Substance in the class of Peptide Hormones, Growth Factors, Related Substances, and Mimetics. Both substances are on the banned list of substances at all time on the UFC Prohibited List under the UFC Anti-Doping Policy. ....

Marion Reneau , Raquel Pennington , Doping Agency , Specified Substance , Anabolic Agents , Peptide Hormones , Growth Factors , Related Substances , மரியன் ரெனோ , ரகெல் பென்னிங்டன் , குறிப்பிடப்பட்டுள்ளது பொருள் , பெப்டைட் ஹார்மோன்கள் , வளர்ச்சி காரணிகள் ,

Raquel Pennington given six-month USADA suspension after disclosing use of banned substances


Raquel Pennington given six-month USADA suspension after disclosing use of banned substances
Share this story
Photo by Chris Unger/Zuffa LLC via Getty Images
Yesterday the US Anti-Doping Agency announced that they had suspended former UFC bantamweight title challenger Raquel Pennington after she self-reported a doping violation. USADA’s statement regarding Pennginton partly read as follows:
Pennington, 32, self-reported the use of two prohibited substances – 7-keto-DHEA and AOD-9064 – to USADA on November 17, 2020. As the result of the declaration, USADA collected an out-of-competition urine sample from Pennington, and subsequent analysis was consistent with her declared use of 7-keto-DHEA. 7-keto-DHEA (7-keto-dehydroepiandrosterone) is a non-Specified Substance in the class of Anabolic Agents and AOD-9064 is a non-Specified Substance in the class of Peptide Hormones, Growth Factors, Related Substances, and Mimetics. Both substances are prohibited at all time ....

Jessica Andrade , Ashlee Evans Smith , Irene Aldana , Marion Reneau , Roxanne Modafferi , Holly Holm , Amanda Nunes , Raquel Pennington , Miesha Tate , Raquel Pennington Rocky , Team Tate , Team Rousey , Doping Agency , Specified Substance , Anabolic Agents , Peptide Hormones , Growth Factors , Related Substances , Doping Policy , Ultimate Fighter , Germaine De Randamie , ஜெசிகா அன்றதே , ஆஷ்லீ எவன்ஸ் ஸ்மித் , ஐரீந் அல்தானா , மரியன் ரெனோ , ஹோலி ஹோல்ம் ,